# | Title | Journal | Year | Citations |
---|
1 | Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease | journal of prevention of Alzheimer's disease, The | 2022 | 201 |
2 | MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA | journal of prevention of Alzheimer's disease, The | 2014 | 149 |
3 | REVISITING THE CHOLINERGIC HYPOTHESIS IN ALZHEIMER’S DISEASE: EMERGING EVIDENCE FROM TRANSLATIONAL AND CLINICAL RESEARCH | journal of prevention of Alzheimer's disease, The | 2019 | 135 |
4 | Aducanumab: Appropriate Use Recommendations | journal of prevention of Alzheimer's disease, The | 2021 | 115 |
5 | The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention | journal of prevention of Alzheimer's disease, The | 2021 | 115 |
6 | MULTIDOMAIN INTERVENTIONS TO PREVENT COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, AND DEMENTIA: FROM FINGER TO WORLD-WIDE FINGERS | journal of prevention of Alzheimer's disease, The | 2020 | 108 |
7 | MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA | journal of prevention of Alzheimer's disease, The | 0 | 106 |
8 | Female Sex and Alzheimer’s Risk: The Menopause Connection | journal of prevention of Alzheimer's disease, The | 2018 | 94 |
9 | Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021 | journal of prevention of Alzheimer's disease, The | 2021 | 90 |
10 | Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies | journal of prevention of Alzheimer's disease, The | 2017 | 90 |
11 | Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease | journal of prevention of Alzheimer's disease, The | 2014 | 80 |
12 | Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease | journal of prevention of Alzheimer's disease, The | 2017 | 70 |
13 | DEVELOPMENT OF AZELIRAGON, AN ORAL SMALL MOLECULE ANTAGONIST OF THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS, FOR THE POTENTIAL SLOWING OF LOSS OF COGNITION IN MILD ALZHEIMER’S DISEASE | journal of prevention of Alzheimer's disease, The | 2018 | 67 |
14 | PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE | journal of prevention of Alzheimer's disease, The | 2016 | 67 |
15 | DEFINING DISEASE MODIFYING THERAPY FOR ALZHEIMER’S DISEASE | journal of prevention of Alzheimer's disease, The | 2017 | 65 |
16 | DIETARY FACTORS AND COGNITIVE DECLINE | journal of prevention of Alzheimer's disease, The | 2016 | 64 |
17 | BIFIDOBACTERIUM BREVE A1 SUPPLEMENTATION IMPROVED COGNITIVE DECLINE IN OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT: AN OPEN-LABEL, SINGLE-ARM STUDY | journal of prevention of Alzheimer's disease, The | 2019 | 59 |
18 | EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN PRIMARY CARE | journal of prevention of Alzheimer's disease, The | 2020 | 58 |
19 | NEUROPSYCHOLOGICAL PROFILE OF “COGNITIVE FRAILTY” SUBJECTS IN MAPT STUDY | journal of prevention of Alzheimer's disease, The | 2016 | 57 |
20 | REVISITING THE HALLMARKS OF AGING TO IDENTIFY MARKERS OF BIOLOGICAL AGE | journal of prevention of Alzheimer's disease, The | 2020 | 56 |
21 | BASELINE SUBJECTIVE MEMORY COMPLAINTS ASSOCIATE WITH INCREASED RISK OF INCIDENT DEMENTIA: THE PREADVISE TRIAL | journal of prevention of Alzheimer's disease, The | 2015 | 55 |
22 | ANTI-TAU TRIALS FOR ALZHEIMER’S DISEASE: A REPORT FROM THE EU/US/CTAD TASK FORCE | journal of prevention of Alzheimer's disease, The | 2019 | 48 |
23 | THE ROAD AHEAD TO CURE ALZHEIMER\'S DISEASE: DEVELOPMENT OF BIOLOGICAL MARKERS AND NEUROIMAGING METHODS FOR PREVENTION TRIALS ACROSS ALL STAGES AND TARGET POPULATIONS | journal of prevention of Alzheimer's disease, The | 2014 | 48 |
24 | THE TIMECOURSE OF GLOBAL COGNITIVE GAINS FROM SUPERVISED COMPUTER-ASSISTED COGNITIVE TRAINING: A RANDOMISED, ACTIVE-CONTROLLED TRIAL IN ELDERLY WITH MULTIPLE DEMENTIA RISK FACTORS | journal of prevention of Alzheimer's disease, The | 2014 | 47 |
25 | COMPUTERIZED COGNITIVE TESTING FOR USE IN CLINICAL TRIALS: A COMPARISON OF THE NIH TOOLBOX AND COGSTATE C3 BATTERIES | journal of prevention of Alzheimer's disease, The | 2017 | 46 |
26 | ARIZONA ALZHEIMER’S REGISTRY: STRATEGY AND OUTCOMES OF A STATEWIDE RESEARCH RECRUITMENT REGISTRY | journal of prevention of Alzheimer's disease, The | 2014 | 46 |
27 | Lecanemab: Appropriate Use Recommendations | journal of prevention of Alzheimer's disease, The | 0 | 46 |
28 | PIMAVANSERIN: POTENTIAL TREATMENT FOR DEMENTIA-RELATED PSYCHOSIS | journal of prevention of Alzheimer's disease, The | 2018 | 44 |
29 | AADVAC1, AN ACTIVE IMMUNOTHERAPY FOR ALZHEIMER’S DISEASE AND NON ALZHEIMER TAUOPATHIES: AN OVERVIEW OF PRECLINICAL AND CLINICAL DEVELOPMENT | journal of prevention of Alzheimer's disease, The | 2019 | 44 |
30 | PLASMA BIOMARKERS OF AD EMERGING AS ESSENTIAL TOOLS FOR DRUG DEVELOPMENT: AN EU/US CTAD TASK FORCE REPORT | journal of prevention of Alzheimer's disease, The | 2019 | 43 |
31 | BLOOD-BRAIN BARRIER PERMEABILITY IN AGING AND ALZHEIMER’S DISEASE | journal of prevention of Alzheimer's disease, The | 2014 | 43 |
32 | MEDITERRANEAN DIET AND MAGNETIC RESONANCE IMAGING-ASSESSED BRAIN ATROPHY IN COGNITIVELY NORMAL INDIVIDUALS AT RISK FOR ALZHEIMER’S DISEASE | journal of prevention of Alzheimer's disease, The | 0 | 43 |
33 | INCREASED FUNCTIONAL CONNECTIVITY AFTER LISTENING TO FAVORED MUSIC IN ADULTS WITH ALZHEIMER DEMENTIA | journal of prevention of Alzheimer's disease, The | 2019 | 41 |
34 | PLASMA A?42/40 RATIO DETECTS EARLY STAGES OF ALZHEIMER’S DISEASE AND CORRELATES WITH CSF AND NEUROIMAGING BIOMARKERS IN THE AB255 STUDY | journal of prevention of Alzheimer's disease, The | 2019 | 41 |
35 | Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease | journal of prevention of Alzheimer's disease, The | 2017 | 41 |
36 | Aducanumab: Appropriate Use Recommendations Update | journal of prevention of Alzheimer's disease, The | 2022 | 41 |
37 | THE FEASIBILITY OF AT-HOME IPAD COGNITIVE TESTING FOR USE IN CLINICAL TRIALS | journal of prevention of Alzheimer's disease, The | 2016 | 39 |
38 | RE-ENGINEERING ALZHEIMER CLINICAL TRIALS: GLOBAL ALZHEIMER’S PLATFORM NETWORK | journal of prevention of Alzheimer's disease, The | 2016 | 38 |
39 | EARLY DETECTION OF MILD COGNITIVE IMPAIRMENT (MCI) IN AN AT-HOME SETTING | journal of prevention of Alzheimer's disease, The | 2020 | 38 |
40 | INTEGRATED CARE FOR OLDER PEOPLE AND THE IMPLEMENTATION IN THE INSPIRE CARE COHORT | journal of prevention of Alzheimer's disease, The | 2020 | 38 |
41 | STRONG RELATIONSHIP BETWEEN MALNUTRITION AND COGNITIVE FRAILTY IN THE SINGAPORE LONGITUDINAL AGEING STUDIES (SLAS-1 AND SLAS-2) | journal of prevention of Alzheimer's disease, The | 2018 | 37 |
42 | RATIONALE FOR EARLY DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT (MCI) SUPPORTED BY EMERGING DIGITAL TECHNOLOGIES | journal of prevention of Alzheimer's disease, The | 2020 | 37 |
43 | RATIONALE AND STRUCTURE FOR A NEW CENTER FOR STUDIES ON PREVENTION OF ALZHEIMER’S DISEASE (STOP-AD) | journal of prevention of Alzheimer's disease, The | 2016 | 37 |
44 | BRIDGING THE TRANSLATION GAP: FROM DEMENTIA RISK ASSESSMENT TO ADVICE ON RISK REDUCTION | journal of prevention of Alzheimer's disease, The | 2015 | 36 |
45 | REGISTRIES AND COHORTS TO ACCELERATE EARLY PHASE ALZHEIMER’S TRIALS. A REPORT FROM THE E.U./U.S. CLINICAL TRIALS IN ALZHEIMER’S DISEASE TASK FORCE | journal of prevention of Alzheimer's disease, The | 2016 | 36 |
46 | ENDPOINTS FOR PRE-DEMENTIA AD TRIALS: A REPORT FROM THE EU/US/CTAD TASK FORCE | journal of prevention of Alzheimer's disease, The | 2015 | 35 |
47 | COGNITIVE FRAILTY AND INCIDENCE OF DEMENTIA IN OLDER PERSONS | journal of prevention of Alzheimer's disease, The | 2018 | 34 |
48 | EVALUATION OF THE NEUROPROTECTIVE POTENTIAL OF N-ACETYLCYSTEINE FOR PREVENTION AND TREATMENT OF COGNITIVE AGING AND DEMENTIA | journal of prevention of Alzheimer's disease, The | 2017 | 34 |
49 | CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4/4 HOMOZYGOUS PATIENTS WITH MILD ALZHEIMER’S DISEASE SUGGEST DISEASE MODIFICATION POTENTIAL | journal of prevention of Alzheimer's disease, The | 2017 | 34 |
50 | THE FUTURE OF ANTI-AMYLOID TRIALS | journal of prevention of Alzheimer's disease, The | 2020 | 34 |